Conference Calendar

September 18-20 - American Society for Surgery of the Hand Annual Meeting

October 1-3 - EuroSpine 2014

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

Offerings

ReWalk Robotics Prices IPO BY ANDREW VAHRADIAN, SEPTEMBER 22, 2014

ReWalk Robotics priced its initial public offering (IPO) of 3.0 million shares of common stock at a price of $12.00 per share, raising total proceeds of $36 million. This equates to an enterprise value of approximately $155 million. The final... more

ReWalk Robotics Proposes Terms for IPO BY ANDREW VAHRADIAN, SEPTEMBER 5, 2014

ReWalk Robotics filed to raise between $54 million and $60 million through a previously 3634">announced initial public offering (IPO), by offering 3.4 million shares of common stock at a proposed price range of $14-$16 a share. At the midpoint of... more

Smith & Nephew Unveils New Discounted, Hospital-focused Sales Model BY ANDREW VAHRADIAN, AUGUST 14, 2014

Smith & Nephew unveiled a new hospital-focused sales model that will offer two of the company's primary hip and knee implants through multiyear contracts at an approximate discounted rate of one-third.
Pages-from-smith_nephew_q2_2014_results_presentation.png more

Spinal Kinetics Completes $34M Financing and Settles IP Litigation with Johnson & Johnson BY ANDREW VAHRADIAN, JUNE 5, 2014

Spinal Kinetics completed a $34 million private financing and entered a global settlement of all patent litigation with Synthes and Depuy Synthes (Johnson & Johnson) with respect its M6 Cervical and Lumbar artificial disc implants. The company's M6-C artificial cervical... more

Orthocell Limited Announces IPO BY ANDREW VAHRADIAN, JUNE 2, 2014

Orthocell Limited announced its intention to list on the Australian Securities Exchange (ASX) by launching an initial public offering (IPO) process, proposing to raise $8 million by offering 20 million shares at an offer price of $0.40 a share. Orthocell... more

K2M Prices IPO BY ANDREW VAHRADIAN, MAY 8, 2014

K2M priced its initial public offering (IPO) of 8,825,000 shares of common stock at a price of $15.00 per share, raising total proceeds of $132 million. This equates to an enterprise value of approximately $595 million, or 3.8x LTM revenues.... more

K2M Proposes Terms for IPO BY ANDREW VAHRADIAN, APRIL 22, 2014

K2M filed to raise between $141 million and $159 million through a previously announced initial public offering (IPO), by offering 8.8 million shares of common stock at a proposed price range of $16-$18 a share. At the midpoint of the... more

K2M Proposes $100M IPO BY ANDREW VAHRADIAN, MARCH 17, 2014

K2M filed to raise up to $100 million through a previously announced initial public offering (IPO) of common shares. The price range and number of shares to be sold in the offering has not yet been determined. The company plans... more

Biomet Files for Proposed IPO BY ANDREW VAHRADIAN, MARCH 7, 2014

Biomet officially announced that its parent company, LVB Acquisition, filed a registration statement with the Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of its common stock. The number of shares to be offered and the... more

Biomet Expected to Launch IPO BY ANDREW VAHRADIAN, FEBRUARY 28, 2014

Biomet, Inc. is reported to have hired Bank of America Merrill Lynch (BAML), Goldman Sachs (GS) and JPMorgan Chase & Co (JPM) to lead an initial public offering (IPO) that could take place as early as 1H:14, and raise potentially... more

Amedica Prices IPO BY ANDREW VAHRADIAN, FEBRUARY 19, 2014

Amedica Corporation priced its initial public offering (IPO) of 3,500,000 shares of common stock at a public offering price of $5.75 per share, raising total proceeds of $20 million. This equates to an enterprise value of approximately $97 million, or... more

Titan Medical Prices an Increased Equity Offering Size BY ANDREW VAHRADIAN, FEBRUARY 13, 2014

Titan Medical increased the size of its public equity offering announced last week. The company plans to offer a minimum of 5,720,000 units and a maximum of 7,950,000 units at a price of $1.40 per unit for a maximum total... more

Amedica Prices IPO BY ANDREW VAHRADIAN, JANUARY 30, 2014

Amedica Corporation announced terms for its initial public offering (IPO) earlier this week, further demonstrating that orthopedics and spine is coming back into favor with the public investment community. The company plans to raise between $32 million and $38 million... more

K2M Files for IPO BY ANDREW VAHRADIAN, JANUARY 27, 2014

Another sign that orthopedics and spine is coming back into favor with the investment community has emerged with K2M Group announcing its filing to do an initial public offering (IPO). K2M has formally submitted its draft registration statement (Form S-1)... more

MiMedx Prices $34 million Public Offering BY ANDREW VAHRADIAN, DECEMBER 18, 2013

MiMedx Group, Inc., a developer of regenerative biomaterials and bioimplants processed from human amniotic membrane, priced an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $6.80 per share for gross proceeds... more

Baxano Surgical Secures $22M in Financing Commitments BY ANDREW VAHRADIAN, DECEMBER 6, 2013

Baxano Surgical, a comany that develops minimally invasive products to treat degenerative spinal conditions affecting the lumbar region, secured a comprehensive financing package that entails a credit facility of up to $15.0 million with Hercules Technology Growth Capital, and a... more

Amedica Announces Public Offering BY ANDREW VAHRADIAN, NOVEMBER 18, 2013

Amedica announced plans to launch an initial public offering (IPO) to raise up to $35 million. The Salt Lake City company specializes in silicon nitride-based implants used during joint-replacement and spinal procedures. The company had previously filed for an IPO... more

OrthoAccel Technologies, Inc. Secures Debt Facility of up to $4 million with Comerica Bank BY EDITOR, NOVEMBER 15, 2013

OrthoAccel Technologies, Inc. announced today that it has executed a debt facility for up to $4 million with Comerica Bank. The credit facility provides for up to $4 million in term debt and the issuance to Comerica of a warrant... more

Mazor Robotics Files for Public Offering of American Depositary Shares BY ANDREW VAHRADIAN, OCTOBER 22, 2013

Mazor Robotics filed a preliminary prospectus with the US Securities and Exchange Commission (SEC) to issue two million American Depository Shares (ADSs) in a public offering to raise approximately $40-46 million. The shares would trade on the NASDAQ Stock Market... more

LDR Holding Completes IPO BY ANDREW VAHRADIAN, OCTOBER 9, 2013

LDR Holding priced its initial public offering (IPO) and began trading on the NASDAQ Stock Market under the ticker symbol "LDRH" today. The company raised $75 million by offering 5.0 million shares priced at $15 a share, the midpoint of... more

Musculoskeletal News Roundup 26-Sept-13 BY LAUREN UZDIENSKI, SEPTEMBER 26, 2013

SYK to acquire MAKO ... Crosstress Medical receives 510(k) clearance for PVA Pod System ... PlusLife's Allogeneic Bone Gel for sale ... Integra announces first implantation of the Titan Reverse Shoulder System ... RTI Surgical's first implantation of the map3 Cellular Allogeneic Bone Graft ... Mazor Robotics to raise up to $46M in Nasdaq offering and announces new Renaissance installation in Russia more

Alphatec Spine Announces Restructured and Expanded Credit Facility BY EDITOR, SEPTEMBER 17, 2013

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it has amended its existing credit facility with MidCap Financial. The revised credit... more

Aurora Spine Completes IPO BY ANDREW VAHRADIAN, SEPTEMBER 9, 2013

Aurora Spine Corporation completed its initial public offering (IPO) of 5,150,000 common shares at a price per share of $0.70, for total gross proceeds of $3,605,000. Aurora Spine's common shares are expected to commence trading on the TSX Venture Exchange... more

Strong Quarter for Healthcare in Venture Capital Investment and Deal Volume BY ANDREW VAHRADIAN, JULY 26, 2013

According to the Venture Capital Activity Report issued by CB Insights for 2Q:13, the share of early-stage deals in the 2Q:13 as a percentage of overall healthcare deals accounted for 41% of overall number of deals, a five-quarter high. The... more

Aurora Spine Files Preliminary Prospectus to go Public BY ANDREW VAHRADIAN, JULY 18, 2013

Aurora Spine Corporation announced that it has filed a preliminary prospectus with the securities regulatory authorities in the Canadian provinces of Alberta and Ontario in connection with a proposed initial public offering (IPO) of common shares for total gross proceeds... more

Investors Eye Medical Device Industry BY ANDREW VAHRADIAN, JANUARY 24, 2013

Over the course of 2012, the medical device industry saw a significant increase in the amount of capital received and the level of interest from angel and seed investors. In 2012, there were 457 medtech angel- and seed-round financings equating... more


Complete Archive